4-Biphenylacetic acid (BPA) is a potential non-steroidal anti-inflammatory agent and forms solid inclusion complex with β-cyclodextrin. Its interaction with quinolone antibacterial agents can induce functional blockade of the γ-aminobutyric acid receptors.
4-Biphenylacetic acid (BPAA) is a prostaglandin-synthesis inhibitor[1].
4-Biphenylacetic acid (BPAA) markedly inhibits the ocular effects of both chemically and mechanically induced trauma[1].
[1] Tolman EL, et al. Invest Ophthalmol. 1976, 15(12):1005-8.
















